SB 212 revises Louisiana’s medical malpractice statutes in several ways. It keeps the general malpractice damages cap at $500,000 per claimant, exclusive of past and future medical care and related benefits and loss of income or earning capacity, but adds language tying the cap to inflation through the Consumer Price Index for Urban Wage Earners and Clerical Workers. The bill also changes how future medical care and related benefits are handled after a malpractice judgment or settlement, replacing several existing procedures with a new framework that requires a post-trial evidentiary hearing on whether the patient, minor patient’s tutor, or curator is competent to manage the award.
If the court finds the recipient competent, the future medical award is paid directly as other damages. If the court finds the recipient not competent, the bill directs that the award be placed into a qualified trust for the victim’s benefit, with any remaining assets passing to heirs or legatees at death. SB 212 also repeals multiple existing provisions governing the Patient Compensation Fund’s ongoing oversight of future medical benefits, including provisions for periodic physical examinations, related attorney-fee consequences, and expert-witness testimony in termination proceedings. The bill retains the ability for parties to enter court-approved settlements for limited or partial medical benefits.
The bill further changes malpractice filing procedures by allowing claimants to either proceed through a medical review panel or file in court with a certificate of merit. The certificate must be supported by an affidavit from the claimant, the claimant’s attorney, or a licensed physician and must establish a good-faith basis for the claim or a physician’s conclusion that the defendant’s conduct fell below the standard of care and caused injury or death. If expert consultation cannot be obtained before prescription would bar the claim, the certificate may be filed within 90 days after all defendants answer, but failure to do so results in dismissal. A single certificate of merit is sufficient even if multiple defendants are named.
The bill’s impact on state law would be significant for malpractice litigation, especially in how future medical damages are administered and how claims are initiated. It would amend Louisiana Revised Statutes 40:1231.2, 40:1231.3, and 40:1231.8, while repealing several subsections that currently govern Patient Compensation Fund procedures for future care. It would also shift some malpractice cases toward a certificate-of-merit filing model, potentially affecting plaintiffs, health care providers, the Patient Compensation Fund, and courts handling malpractice claims.
No committee testimony or recorded votes were provided, so the overall sentiment cannot be measured from debate history. Based on the bill text alone, the measure appears to favor tighter procedural screening of claims and a more structured approach to future medical awards, while also preserving claimant access to court and maintaining the existing damages cap framework. Likely points of contention include the new certificate-of-merit requirement, the repeal of existing Patient Compensation Fund oversight procedures, and the new competency hearing/trust mechanism for future medical awards, which may be viewed differently by plaintiffs’ advocates, defense interests, and medical providers.
SB 212 would amend Louisiana’s medical malpractice laws by revising the damages cap language, adding CPI-based inflation adjustment language, and restructuring the handling of future medical care and related benefits. It would repeal several existing provisions in R.S. 40:1231.3 governing Patient Compensation Fund administration of future medical awards and replace them with a post-trial competency hearing and trust-based payment mechanism in certain cases. It would also amend filing procedures in R.S. 40:1231.8 to allow a claimant to proceed either through a medical review panel or by filing in court with a certificate of merit, affecting malpractice plaintiffs, health care providers, the Patient Compensation Fund, and the courts.
No votes or committee discussion were provided, and the bill is listed as pending in Senate Judiciary A, so there is no recorded legislative sentiment to summarize from the available history. From the text, the bill appears to be a substantive malpractice reform measure that combines claimant-facing procedural requirements with changes to how future medical benefits are paid and managed. Its structure suggests support for more formal claim screening and more controlled administration of future awards, but the absence of debate makes the level of support or opposition unclear.
Likely areas of contention include the certificate-of-merit requirement, which may be seen as a barrier to filing by some claimant advocates, and the repeal of existing Patient Compensation Fund procedures for monitoring future medical care, which could draw concern from those who favor continued oversight. The new post-trial competency hearing and qualified trust requirement may also be disputed because it changes who controls future medical awards and how those funds are distributed. Health care providers and malpractice defense interests may favor the procedural screening and administrative changes, while plaintiffs’ attorneys and patient advocates may object to added hurdles or reduced flexibility in managing awards.